Posts

Showing posts with the label first-gen pharma

Readers Choice

Navigating the Unknown: Leadership in an Era of Uncertainty

-
Image
 Leading through the mists of uncertainty can feel formidable; yet, it unveils a chance to display resilience, adaptability, and visionary leadership. Here are a tapestry of strategies to amplify your prowess in traversing unpredictable realms: Embrace Flexibility and Adaptability Stay Agile: Nurture a malleable work atmosphere that empowers teams to swiftly shift and respond to emerging insights and changing tides. Iterative Planning: Break down long-term visions into smaller, manageable milestones that can be recalibrated as needed, allowing for continual reassessment and evolution. Communicate Transparently Honest Updates: Keep your team apprised of the current landscape, even when the news is less than favorable. Transparency begets trust and ensures collective alignment. Open Dialogue: Foster a space where team members feel emboldened to express their concerns and ideas, enriching insights and uplifting morale. Focus on What You Can Control Identify Priorities: Direct your ene...
Post a Comment
Read more

Chennai Pharma Entrepreneur Braved Odds To Sell Meds In Latin America

-
Image
When C.C. Paarthipan, a first-gen pharma entrepreneur, listed his tiny Chennai company, Caplin Point Labs–with revenues of less than $1 million–it was oversubscribed 117 times. He raised about $900,000 in the 1994 IPO and deployed it in a formulations plant in Pondicherry. But in just a few years the company got mired in quality-control issues; consignments were rejected, and it became a penny stock. “I couldn’t pay my sons’ school fees–my company had become a non performing asset,” recalls Paarthipan, 62. “That’s when I took the risk of going to places where most people fear to go.” He packed his bags and left for Africa and then Latin America. He braved the weather, the food, guns, drug lords and competitors to set up a base. He networked with importers and pharmacies to forge deals in these semiregulated markets, which lack the stringency of the U.S. market. The early move to Latin America has differentiated Caplin because small Indian pharmas that choose to export typic...
Post a Comment
Read more